DOCSLIB.ORG

Generic Drugs and Trade Name Equivalents

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

GENERIC DRUGS AND TRADE NAME EQUIVALENTS Generic Trade Generic Trade Generic Trade acetaminophen Tylenol esomeprazole Nexium naphazoline Naphcon acetazolamide Diamox ethambutol Myambutol naproxen Aleve acetylcysteine Mucomyst famciclovir Famvir natamycin Natacyn acyclovir Zovirax famotidine Pepcid nedocromil Tilade albuterol Ventolin fexofenadine Allegra neostigmine Prostigmin allopurinol Zyloprim fluconazole Diflucan nepafenac Nevanac amantadine Symmetrel fluorometholone FML nifedipine Procardia amiodarone Cordarone fluoxetine Prozac nystatin Mycostatin amitriptyline Elavil flurbiprofen Ocufen ofloxacin Ocuflox amoxicillin Principen fluticasone Flonase or olopatadine Patanol amphotericin B Amphocin Flovent omeprazole Prilosec apraclonidine Iopidine foscarnet Foscavir oseltamivir Tamiflu atenolol Tenormin furosemide Lasix oxycodone Roxicodone atorvastatin Lipitor ganciclovir Zirgan pegaptanib Macugen azathioprine Imuran gatifloxacin Zymar pemirolast Alamast azelastine Optivar gemfibrozil Lopid penicillamine Cuprimine azithromycin Zithromax gentamicin Garamycin phenelzine Nardil or Azasite glipizide Glucotrol phenobarbital Luminal benazepril Lotensin glyburide Diabeta or phenylephrine Neo-Synephrine bepotastine Bepreve Micronase phenytoin Dilantin besifloxacin Besivance glycerin Osmoglyn pioglitazone Actos betaxolol Betoptic S griseofulvin Grifulvin V piroxicam Feldene bimatoprost Lumigan hydralazine Apresoline pralidoxime Protopam botulinum toxin Botox hydrochlorothiazide Hydrodiuril prazosin Minipress brimonidine Alphagan P hydrocortisone Cortef promethazine Phenergan brinzolamide Azopt hydroxychloroquine Plaquenil proparacaine Ophthaine bromfenac Xibrom ibuprofen Motrin or propranolol Inderal bromocriptine Parlodel Advil pseudoephedrine Sudafed brompheniramine Dimetane imipramine Tofranil pyridostigmine Mestinon captopril Capoten indomethacin Indocin pyrimethamine Daraprim carteolol Ocupress ipratropium Atrovent ranibizumab Lucentis ceftriaxone Rocephin isoniazid Nydrazid ranitidine Zantac celecoxib Celebrex isoproterenol Isuprel ribavirin Copegus or cephalexin Keflex isotretinoin Accutane Rebetol cetirizine Zyrtec ketoconazole Nizoral rifampin Rifadin chloramphenicol Chloromycetin ketorolac Acular or rimexolone Vexol or Chloroptic Toradol salmeterol Serevent chloroquine Aralen ketotifen Zaditor sildenafil Viagra chlorothiazide Diuril labetalol Trandate simvastatin Zocor chlorpheniramine Chlor-Trimeton latanoprost Xalatan sodium chloride Muro-128 chlorpromazine Thorazine levalbuterol Xopenex spironolactone Aldactone chlorpropamide Diabinese levobunolol Betagan sucralfate Carafate cholestyramine Questran levofloxacin Quixin sulfacetamide Sulamyd cimetidine Tagamet levothyroxine Synthroid sulfadiazine Microsulfan ciprofloxacin Ciloxan or Cipro lidocaine Xylocaine sulfamethoxazole Gantanol clarithromycin Biaxin lindane Kwell sulfisoxazole Gantrisin clindamycin Cleocin lisinopril Prinivil or sumatriptan Imitrex clonidine Catapres Zestril tamoxifen Nolvadex cromolyn sodium Crolom lodoxamide Alomide tamsulosin Flomax cyclobenzaprine Flexeril loratadine Claritin terazosin Hytrin cyclopentolate Cyclogyl losartan Cozaar terbutaline Brethine cyclosporine Neoral or loteprednol Alrex or tetrahydrozoline Visine Sandimmune Lotemax theophylline Theo-Dur dexamethasone Maxidex lovastatin Mevacor thioridazine Mellaril dextroamphetamine Dexedrine mannitol Osmitrol timolol Timoptic diazepam Valium meperidine Demerol tobramycin Tobrex diclofenac Voltaren metaproterenol Alupent tramadol Ultram dicloxacillin Dynapen metformin Glucophage travoprost Travatan difluprednate Durezol methazolamide Neptazane triamcinolone Aristocort or digoxin Lanoxin methotrexate Rheumatrex Kenalog diltiazem Cardizem methylphenidate Ritalin triamterene Dyrenium diphenhydramine Benadryl metipranolol OptiPranolol trifluridine Viroptic dipyridamole Persantine metoprolol Lopressor trimethoprim Primsol donepezil Aricept metronidazole MetroGel or tropicamide Mydriacyl dorzolamide Trusopt MetroCream valacyclovir Valtrex echothiophate Phospholine miconazole Monistat-Derm vardenafil Levitra edrophonium Enlon montelukast Singulair verapamil Calan or Isoptin emedastine Emadine moxifloxacin Vigamox or warfarin Coumadin enalapril Vasotec Avelox zafirlukast Accolate epinastine Elestat naloxone Narcan zidovudine Retrovir Copyright © 2011 National Board of Examiners in Optometry®. All rights reserved. .
Recommended publications
  • The National Drugs List

    The National Drugs List

    ^ ^ ^ ^ ^[ ^ The National Drugs List Of Syrian Arab Republic Sexth Edition 2006 ! " # "$ % &'() " # * +$, -. / & 0 /+12 3 4" 5 "$ . "$ 67"5,) 0 " /! !2 4? @ % 88 9 3: " # "$ ;+<=2 – G# H H2 I) – 6( – 65 : A B C "5 : , D )* . J!* HK"3 H"$ T ) 4 B K<) +$ LMA N O 3 4P<B &Q / RS ) H< C4VH /430 / 1988 V W* < C A GQ ") 4V / 1000 / C4VH /820 / 2001 V XX K<# C ,V /500 / 1992 V "!X V /946 / 2004 V Z < C V /914 / 2003 V ) < ] +$, [2 / ,) @# @ S%Q2 J"= [ &<\ @ +$ LMA 1 O \ . S X '( ^ & M_ `AB @ &' 3 4" + @ V= 4 )\ " : N " # "$ 6 ) G" 3Q + a C G /<"B d3: C K7 e , fM 4 Q b"$ " < $\ c"7: 5) G . HHH3Q J # Hg ' V"h 6< G* H5 !" # $%" & $' ,* ( )* + 2 ا اوا ادو +% 5 j 2 i1 6 B J' 6<X " 6"[ i2 "$ "< * i3 10 6 i4 11 6! ^ i5 13 6<X "!# * i6 15 7 G!, 6 - k 24"$d dl ?K V *4V h 63[46 ' i8 19 Adl 20 "( 2 i9 20 G Q) 6 i10 20 a 6 m[, 6 i11 21 ?K V $n i12 21 "% * i13 23 b+ 6 i14 23 oe C * i15 24 !, 2 6\ i16 25 C V pq * i17 26 ( S 6) 1, ++ &"r i19 3 +% 27 G 6 ""% i19 28 ^ Ks 2 i20 31 % Ks 2 i21 32 s * i22 35 " " * i23 37 "$ * i24 38 6" i25 39 V t h Gu* v!* 2 i26 39 ( 2 i27 40 B w< Ks 2 i28 40 d C &"r i29 42 "' 6 i30 42 " * i31 42 ":< * i32 5 ./ 0" -33 4 : ANAESTHETICS $ 1 2 -1 :GENERAL ANAESTHETICS AND OXYGEN 4 $1 2 2- ATRACURIUM BESYLATE DROPERIDOL ETHER FENTANYL HALOTHANE ISOFLURANE KETAMINE HCL NITROUS OXIDE OXYGEN PROPOFOL REMIFENTANIL SEVOFLURANE SUFENTANIL THIOPENTAL :LOCAL ANAESTHETICS !67$1 2 -5 AMYLEINE HCL=AMYLOCAINE ARTICAINE BENZOCAINE BUPIVACAINE CINCHOCAINE LIDOCAINE MEPIVACAINE OXETHAZAINE PRAMOXINE PRILOCAINE PREOPERATIVE MEDICATION & SEDATION FOR 9*: ;< " 2 -8 : : SHORT -TERM PROCEDURES ATROPINE DIAZEPAM INJ.
  • (CD-P-PH/PHO) Report Classification/Justifica

    (CD-P-PH/PHO) Report Classification/Justifica

    COMMITTEE OF EXPERTS ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY (CD-P-PH/PHO) Report classification/justification of medicines belonging to the ATC group D07A (Corticosteroids, Plain) Table of Contents Page INTRODUCTION 4 DISCLAIMER 6 GLOSSARY OF TERMS USED IN THIS DOCUMENT 7 ACTIVE SUBSTANCES Methylprednisolone (ATC: D07AA01) 8 Hydrocortisone (ATC: D07AA02) 9 Prednisolone (ATC: D07AA03) 11 Clobetasone (ATC: D07AB01) 13 Hydrocortisone butyrate (ATC: D07AB02) 16 Flumetasone (ATC: D07AB03) 18 Fluocortin (ATC: D07AB04) 21 Fluperolone (ATC: D07AB05) 22 Fluorometholone (ATC: D07AB06) 23 Fluprednidene (ATC: D07AB07) 24 Desonide (ATC: D07AB08) 25 Triamcinolone (ATC: D07AB09) 27 Alclometasone (ATC: D07AB10) 29 Hydrocortisone buteprate (ATC: D07AB11) 31 Dexamethasone (ATC: D07AB19) 32 Clocortolone (ATC: D07AB21) 34 Combinations of Corticosteroids (ATC: D07AB30) 35 Betamethasone (ATC: D07AC01) 36 Fluclorolone (ATC: D07AC02) 39 Desoximetasone (ATC: D07AC03) 40 Fluocinolone Acetonide (ATC: D07AC04) 43 Fluocortolone (ATC: D07AC05) 46 2 Diflucortolone (ATC: D07AC06) 47 Fludroxycortide (ATC: D07AC07) 50 Fluocinonide (ATC: D07AC08) 51 Budesonide (ATC: D07AC09) 54 Diflorasone (ATC: D07AC10) 55 Amcinonide (ATC: D07AC11) 56 Halometasone (ATC: D07AC12) 57 Mometasone (ATC: D07AC13) 58 Methylprednisolone Aceponate (ATC: D07AC14) 62 Beclometasone (ATC: D07AC15) 65 Hydrocortisone Aceponate (ATC: D07AC16) 68 Fluticasone (ATC: D07AC17) 69 Prednicarbate (ATC: D07AC18) 73 Difluprednate (ATC: D07AC19) 76 Ulobetasol (ATC: D07AC21) 77 Clobetasol (ATC: D07AD01) 78 Halcinonide (ATC: D07AD02) 81 LIST OF AUTHORS 82 3 INTRODUCTION The availability of medicines with or without a medical prescription has implications on patient safety, accessibility of medicines to patients and responsible management of healthcare expenditure. The decision on prescription status and related supply conditions is a core competency of national health authorities.
  • AHFS Pharmacologic-Therapeutic Classification System

    AHFS Pharmacologic-Therapeutic Classification System

    AHFS Pharmacologic-Therapeutic Classification System Abacavir 48:24 - Mucolytic Agents - 382638 8:18.08.20 - HIV Nucleoside and Nucleotide Reverse Acitretin 84:92 - Skin and Mucous Membrane Agents, Abaloparatide 68:24.08 - Parathyroid Agents - 317036 Aclidinium Abatacept 12:08.08 - Antimuscarinics/Antispasmodics - 313022 92:36 - Disease-modifying Antirheumatic Drugs - Acrivastine 92:20 - Immunomodulatory Agents - 306003 4:08 - Second Generation Antihistamines - 394040 Abciximab 48:04.08 - Second Generation Antihistamines - 394040 20:12.18 - Platelet-aggregation Inhibitors - 395014 Acyclovir Abemaciclib 8:18.32 - Nucleosides and Nucleotides - 381045 10:00 - Antineoplastic Agents - 317058 84:04.06 - Antivirals - 381036 Abiraterone Adalimumab; -adaz 10:00 - Antineoplastic Agents - 311027 92:36 - Disease-modifying Antirheumatic Drugs - AbobotulinumtoxinA 56:92 - GI Drugs, Miscellaneous - 302046 92:20 - Immunomodulatory Agents - 302046 92:92 - Other Miscellaneous Therapeutic Agents - 12:20.92 - Skeletal Muscle Relaxants, Miscellaneous - Adapalene 84:92 - Skin and Mucous Membrane Agents, Acalabrutinib 10:00 - Antineoplastic Agents - 317059 Adefovir Acamprosate 8:18.32 - Nucleosides and Nucleotides - 302036 28:92 - Central Nervous System Agents, Adenosine 24:04.04.24 - Class IV Antiarrhythmics - 304010 Acarbose Adenovirus Vaccine Live Oral 68:20.02 - alpha-Glucosidase Inhibitors - 396015 80:12 - Vaccines - 315016 Acebutolol Ado-Trastuzumab 24:24 - beta-Adrenergic Blocking Agents - 387003 10:00 - Antineoplastic Agents - 313041 12:16.08.08 - Selective
  • A Note on Medical Management of Uveitis Apurupa Nedunuri Department of Pharmacology, Osmania University, Hyderabad, India

    A Note on Medical Management of Uveitis Apurupa Nedunuri Department of Pharmacology, Osmania University, Hyderabad, India

    OPEN ACCESS Freely available online e Journal of Pharmacovigilance ISSN: 2329-6887 Mini Review A Note on Medical Management of Uveitis Apurupa Nedunuri Department of Pharmacology, Osmania University, Hyderabad, India ABSTRACT Uveitis is a moving illness to treat. Corticosteroids have been utilized in the treatment of uveitis for a long time. Immunosuppressives are acquiring force lately in the treatment of uveitis. In this article we present an outline of current treatment of uveitis and the significant discoveries and advances in medications and visual medication conveyance frameworks in the treatment of uveitis. Keywords: Corticosteroids; Immunosuppressives; Medical Management; Uveitis. INTRODUCTION prednisolone acetic acid derivation is multiple times less powerful on a molar premise than betamethasone or dexamethasone, the Uveitis is a potentially sight threatening disease. It may occur due entrance into the cornea of prednisolone acetic acid derivation is to an infection or may be due to an autoimmune etiology. Specific significantly more than betamethasone or dexamethasone. Dosing antimicrobial therapies with or without corticosteroids are used recurrence and the time span the medicine stays in contact with in cases of infectious uveitis. Several drugs are available for the visual surface additionally impacts adequacy. Suspensions have a management of non-infectious uveitis including corticosteroids, immunosuppressive agents, and more recently biologics. The more serious level of calming impact. treatment of uveitis is evolving
  • Api Product Portfolio

    Api Product Portfolio

    API PRODUCT PORTFOLIO Farmabios is the global leader in manufacturing Steroids . 1-3 nonsterile and sterile steroids, with a focused Sterile Steroids . 3-4 portfolio of High Potent Substances (HPS) and High Potent Substances . 4 anticancer drugs. Cannabinoids . 4 Antineoplastics . 4 Developments . 4 PharmaZell offers a focused portfolio of small molecule APIs for the generic and originator Small Molecules . 5-6 pharmaceutical industry. Developments . 6 Active Ingredient Therapeutic Monograph Available Regulatory CAS Number Areas Grades Documentation Steroids Amcinonide Dermatologic USP Micronized EU DMF 51022-69-6 Beclomethasone EU DMF PH.EUR. Standard Dipropionate Respiratory US DMF USP Micronized 5534-09-8 CEP Beclomethasone Dipropionate PH.EUR. EU DMF Respiratory Micronized Monohydrate USP US DMF 77011-63-3 Betamethasone EU DMF PH.EUR. Dipropionate Dermatologic Micronized US DMF USP 5593-20-4 CEP EU DMF Betamethasone PH.EUR. US DMF Valerate Dermatologic Micronized USP JP DMF 2152-44-5 CEP EU DMF PH.EUR. US DMF Budesonide Respiratory USP Micronized CEP 51333-22-3 Gastro-Intestinal JP JP DMF CN DMF Chlormadinone EU DMF PH.EUR. Acetate Contraceptive Micronized JP DMF JP 302-22-7 CEP* EU DMF Clobetasol PH.EUR. US DMF Propionate Dermatologic Micronized USP JP DMF 25122-46-7 CEP Clobetasone Butyrate Dermatologic PH.EUR. Micronized EU DMF 25122-57-0 Clocortolone EU DMF Pivalate Dermatologic USP Micronized US DMF 34097-16-0 Cyproterone EU DMF Acetate Anti-Androgen PH.EUR. Micronized US DMF 427-51-0 CEP Delmadinone Anti-Androgen INTERNAL Acetate Micronized EU DMF (Veterinary) SPEC. 13698-49-2 EU DMF Desonide Dermatologic USP Micronized US DMF 638-94-8 CN DMF Desonide Sodium INTERNAL Ophthalmic Standard EU DMF Phosphate SPEC.
  • Ophthalmic Anti-Inflammatories Therapeutic Class Review (TCR)

    Ophthalmic Anti-Inflammatories Therapeutic Class Review (TCR)

    Ophthalmic Anti-Inflammatories Therapeutic Class Review (TCR) October 20, 2020 No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, digital scanning, or via any information storage or retrieval system without the express written consent of Magellan Rx Management. All requests for permission should be mailed to: Magellan Rx Management Attention: Legal Department 6950 Columbia Gateway Drive Columbia, Maryland 21046 The materials contained herein represent the opinions of the collective authors and editors and should not be construed to be the official representation of any professional organization or group, any state Pharmacy and Therapeutics committee, any state Medicaid Agency, or any other clinical committee. This material is not intended to be relied upon as medical advice for specific medical cases and nothing contained herein should be relied upon by any patient, medical professional or layperson seeking information about a specific course of treatment for a specific medical condition. All readers of this material are responsible for independently obtaining medical advice and guidance from their own physician and/or other medical professional in regard to the best course of treatment for their specific medical condition. This publication, inclusive of all forms contained herein, is intended to be educational in nature and is intended to be used for informational purposes only. Send comments and suggestions to [email protected]. October 2020 Proprietary Information. Restricted Access – Do not disseminate or copy without approval. © 2004-2020 Magellan Rx Management. All Rights Reserved. FDA-APPROVED INDICATIONS Drug Manufacturer Indication(s) Corticosteroids – Ophthalmic Topical dexamethasone (Maxidex®)1 Alcon/Novartis .
  • The Inhaled Steroid Ciclesonide Blocks SARS-Cov-2 RNA Replication by Targeting Viral

    The Inhaled Steroid Ciclesonide Blocks SARS-Cov-2 RNA Replication by Targeting Viral

    bioRxiv preprint doi: https://doi.org/10.1101/2020.08.22.258459; this version posted August 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting viral 2 replication-transcription complex in culture cells 3 4 Shutoku Matsuyamaa#, Miyuki Kawasea, Naganori Naoa, Kazuya Shiratoa, Makoto Ujikeb, Wataru 5 Kamitanic, Masayuki Shimojimad, and Shuetsu Fukushid 6 7 aDepartment of Virology III, National Institute of Infectious Diseases, Tokyo, Japan 8 bFaculty of Veterinary Medicine, Nippon Veterinary and Life Science University, Tokyo, Japan 9 cDepartment of Infectious Diseases and Host Defense, Gunma University Graduate School of 10 Medicine, Gunma, Japan 11 dDepartment of Virology I, National Institute of Infectious Diseases, Tokyo, Japan. 12 13 Running Head: Ciclesonide blocks SARS-CoV-2 replication 14 15 #Address correspondence to Shutoku Matsuyama, [email protected] 16 17 Word count: Abstract 149, Text 3,016 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.22.258459; this version posted August 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 18 Abstract 19 We screened steroid compounds to obtain a drug expected to block host inflammatory responses and 20 MERS-CoV replication. Ciclesonide, an inhaled corticosteroid, suppressed replication of MERS-CoV 21 and other coronaviruses, including SARS-CoV-2, the cause of COVID-19, in cultured cells. The 22 effective concentration (EC90) of ciclesonide for SARS-CoV-2 in differentiated human bronchial 23 tracheal epithelial cells was 0.55 μM.
  • Durezol Treats Postoperative Inflammation and Pain This Powerful Corticosteroid Is an Effective New Option for Postsurgical Care

    Durezol Treats Postoperative Inflammation and Pain This Powerful Corticosteroid Is an Effective New Option for Postsurgical Care

    THERAPEUTICS Durezol Treats Postoperative Inflammation and Pain This powerful corticosteroid is an effective new option for postsurgical care. BY MICHAEL KORENFELD, MD cular surgery has undergone an extraordi- nary evolution. Much of the science that we now take for granted—drugs, instruments, O technology, and procedures—was devel- oped only within the past few decades. As recently as 1973, ophthalmologists’ treatment options were far more limited than they are today. There were no micro- incisions, self-sealing wounds, or Nd:YAG lasers. IOLs were an exciting innovation, but phacoemulsification had yet to be invented. In terms of ocular drugs, pred- nisolone acetate had just been approved for the treat- ment of ocular inflammation. Figure 1. The difluprednate molecule. Today, cataract surgery with IOL implantation is one of the most common surgical procedures performed in the tion of critical proteins, and hinder the creation of fur- United States. Its impressively low rate of complications ther inflammatory mediators.1 also makes it one of the safest operations in this country. The most commonly prescribed ophthalmic cortico- Incisions have become incredibly small, thanks to the steroid is prednisolone acetate 1%, a strong steroid, formu- development of foldable IOLs and other technological lated as a suspension (data on file with Sirion Therapeutics, breakthroughs. Inc.). The standard recommended dosing for this drug is Pharmacological developments, however, have not q.i.d. for the treatment of inflammation. Loteprednol kept pace with the tremendous advances in ocular sur- etabonate, 0.5%, another commonly prescribed steroid, is gery. We physicians need a steroid that treats inflamma- also typically dosed q.i.d.
  • Effective July 1, 2011

    Effective July 1, 2011

    MISSISSIPPI DIVISION OF MEDICAID PREFERRED DRUG LIST Effective July 1, 2011 BODY SYSTEM THERAPEUTIC CLASS PREFERRED AGENTS NON-PREFERRED AGENTS NOTES ANALGESICS ANALGESICS, fentanyl patches AVINZA (morphine) NARCOTIC-LONG-ACTING KADIAN (morphine) BUTRANS (buprenorphine) methadone DURAGESIC (fentanyl) morphine ER EMBEDA (morphine/naltrexone) EXALGO (hydromorphone) OPANA ER (oxymorphone) oxycodone ER OXYCONTIN (oxycodone) RYZOLT (tramadol) ULTRAM ER (tramadol) ANALGESICS, NARCOTIC- acetaminophen/codeine ABSTRAL (fentanyl) SHORT-ACTING aspirin/codeine butalbital/APAP/caffeine/codeine codeine butalbital/ASA/caffeine/codeine dihydrocodeine/ APAP/caffeine DARVON-N (propoxyphene) hydrocodone/APAP DILAUDID liquid (hydromorphone) hydrocodone/ibuprofen fentanyl hydromorphone FENTORA (fentanyl) IBUDONE (hydrocodone/ibuprofen) levorphanol meperidine NUCYNTA (tapentadol) morphine ONSOLIS (fentanyl) oxycodone OPANA (oxymorphone) oxycodone/APAP pentazocine/naloxone oxycodone/aspirin propoxyphene oxycodone/ibuprofen propoxyphene/APAP pentazocine/APAP REPREXAIN tramadol (hydrocodone/ibuprofen) tramadol/APAP RYBIX (tramadol) VIMOVO (naproxen/esomeprazole) ZAMICET (hydrocodone/APAP) ZOLVIT (hydrocodone/APAP) ANALGESICS/ANESTHETICS, FLECTOR (diclofenac epolamine) PENNSAID Solution TOPICAL LIDODERM (lidocaine) (diclofenac sodium ) VOLTAREN Gel (diclofenac sodium) ANTIHYPERURICEMICS allopurinol ULORIC (febuxostat) COLCRYS (colchicine) probenecid probenecid/colchicine ANALGESICS (continued) Unless otherwise stated, the listing of a particular brand or generic
  • Drug Pipeline MONTHLY UPDATE

    Drug Pipeline MONTHLY UPDATE

    Drug Pipeline MONTHLY UPDATE Critical updates in an ever changing environment December 2019 NEW DRUG INFORMATION ™ ● Xcopri (cenobamate): The U.S. Food and Drug Administration (FDA) approved SK Biopharmaceuticals’ Xcopri as an antiepileptic drug for treatment of partial-onset seizures in adults. The approval is based on results from two global, randomized, double-blind, placebo-controlled studies and a large, global, multi-center, open-label safety study that enrolled adults with uncontrolled partial-onset seizures, taking one to three concomitant anti-epileptic drug (AEDs). In these studies, Xcopri demonstrated significant reductions in seizure frequency compared to placebo.1 Drug reaction with eosinophilia and systemic symptoms (DRESS) has been reported with Xcopri use. It has not been established that the risk of DRESS is prevented by a slower titration; however, it should be initiated at 12.5 mg once daily and titrated every two weeks. Xcopri is expected to be available in the United States 2Q2020, after scheduling review by the DEA, which typically occurs within 90 days of FDA approval. Price pending. GENERIC DRUG INFORMATION ® + ● Jadenu (deferasirox): Multiple manufacturers have launched their generic version of Novartis’ Jadenu for treatment of chronic iron overload. Jadenu generated $474 million in U.S. annual sales in 2018. ® ● Apriso (mesalamine ER): Multiple manufactures have launched their generic version of Bausch Health’s Apriso for treatment of ulcerative colitis. Apriso generated $312 million in U.S. annual sales in 2018. ® ● Nubupent (pentamidine isethionate): Fresenius launched their generic version of Seton Pharmaceuticals Nebupent inhaled solution for treatment of complicated lung infections. Nubupent does not have any further regulatory exclusivities.
  • Drug List (SORTED by TRADE with GENERIC EQUIVALENT)

    Drug List (SORTED by TRADE with GENERIC EQUIVALENT)

    NBEO Drug List (SORTED BY TRADE WITH GENERIC EQUIVALENT) Trade Generic Trade Generic Abilify aripiprazole Avandia rosiglitazone Accolate zafirlukast Avastin bevacizumab Accupril quinapril Azasan azathioprine Achromycin tetracycline AzaSite azithromycin Aciphex rabeprazole Avodart dutasteride Actos pioglitazone Azopt brinzolamide Acular ketorolac Bactrim trimethoprim-sulfamethoxazole Acuvail ketorolac Bactrim DS trimethoprim-sulfamethoxazole Advair fluticasone propionate Baquacil polyhexamethylene biguanide Advil ibuprofen Beconase AQ beclomethasone AeroBid flunisolide Benadryl diphenhydramine Afrin oxymetazoline Bepreve Bepotastine besilate Aggrenox aspirin and dipyridamole Besivance besifloxacin Alamast pemirolast Betadine povidone-iodine Alaway ketotifen Betagan levobunolol Aldactone spironolactone Betasept chlorhexidine topical Aleve naproxen sodium Betaseron interferon beta-1b Allegra fexofenadine Betimol timolol Allegra-D fexofenadine-pseudoephedrine Betoptic S betaxolol Alluvia lopinavir Biopatch chlorhexidine topical Alocril nedocromil Blephamide sulfacetamide-prednisolone Alomide lodoxamide Botox onabotulinum toxinA Alphagan P brimonidine Brolene propamidine isethionate Alrex loteprednol 0.2% Bromday bromfenac Ambien zolpidem Calamine zinc oxide and iron oxide Amicar aminocaproic acid Calan verapamil Amoxil amoxicillin Calgon Vesta chlorhexidine topical Amphocin amphotericin B Capoten captopril Anectine succinylcholine Carafate sucralfate Ansaid flurbiprofen Carbocaine mepivacaine HCl injection Antivert meclizine Cardizem diltiazem
  • Sir, Mistaken Eye Drops and Subsequent Instillation of Superglue

    Sir, Mistaken Eye Drops and Subsequent Instillation of Superglue

    Sir, in susceptible (steroid-responsive) patients. Rimexolone Mistaken eye drops and subsequent instillation of 1 % ophthalmic suspension is a recently developed superglue topical corticosteroid with effective anti-inflammatory z 3 A 60-year-old man presented himself to the casualty properties as well as a reduced risk of increased IOP. , department after accidentally instilling superglue into We present a case report of a patient with markedly his eyes. He had traditionally put eye drops in himself in elevated lOP associated with the use of 1% rimexolone the evening. On this occasion he had mistaken his wife's suspension. fingernail glue for the eye drops as it stood on the bedside cabinet. The bottles were very similar in reduced Case report light, as both were a dropper design for delivery and the same compact size. A 52-year-old woman with a history of toxic epidermal Once the glue, of which the major constituent was necrolysis has been attending our institution since 1992. cyanoacrylate, contacted his eye it caused immense As a result of her condition she developed dry eyes sudden pain causing him to close his eye more. The glue which required punctal occlusion and eye lubricants, then set quickly and thus he presented with a including autologous serum drops. She had marked permanently closed eye. The upper lid was adherent to keratinisation of the tarsal conjunctiva especially in the the cornea, as when the eye movements were tested the left eye, which necessitated mucous membrane grafting. lid moved. Her condition was further complicated by metaplastic He was followed up and after two consultations he eyelashes, which were treated with cryotherapy.